BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20081061)

  • 1. L718P mutation in the membrane-proximal cytoplasmic tail of beta 3 promotes abnormal alpha IIb beta 3 clustering and lipid microdomain coalescence, and associates with a thrombasthenia-like phenotype.
    Jayo A; Conde I; Lastres P; Martínez C; Rivera J; Vicente V; González-Manchón C
    Haematologica; 2010 Jul; 95(7):1158-66. PubMed ID: 20081061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation in the β3 cytoplasmic tail causes variant Glanzmann thrombasthenia by abrogating transition of αIIb β3 to an active state.
    Hauschner H; Mor-Cohen R; Seligsohn U; Rosenberg N
    J Thromb Haemost; 2012 Feb; 10(2):289-97. PubMed ID: 22136613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia.
    Chen YP; Djaffar I; Pidard D; Steiner B; Cieutat AM; Caen JP; Rosa JP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10169-73. PubMed ID: 1438206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal cytoplasmic extensions associated with active αIIbβ3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome.
    Hauschner H; Mor-Cohen R; Messineo S; Mansour W; Seligsohn U; Savoia A; Rosenberg N
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):302-8. PubMed ID: 25806962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.
    Wang R; Shattil SJ; Ambruso DR; Newman PJ
    J Clin Invest; 1997 Nov; 100(9):2393-403. PubMed ID: 9351872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missense mutations in the beta(3) subunit have a different impact on the expression and function between alpha(IIb)beta(3) and alpha(v)beta(3).
    Tadokoro S; Tomiyama Y; Honda S; Kashiwagi H; Kosugi S; Shiraga M; Kiyoi T; Kurata Y; Matsuzawa Y
    Blood; 2002 Feb; 99(3):931-8. PubMed ID: 11806996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3.
    Mor-Cohen R; Rosenberg N; Peretz H; Landau M; Coller BS; Awidi A; Seligsohn U
    Thromb Haemost; 2007 Dec; 98(6):1257-65. PubMed ID: 18064323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three novel beta-propeller mutations causing Glanzmann thrombasthenia result in production of normally stable pro-alphaIIb, but variably impaired progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Nelson EJ; Li J; Mitchell WB; Chandy M; Srivastava A; Coller BS
    J Thromb Haemost; 2005 Dec; 3(12):2773-83. PubMed ID: 16359515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine 752 in the cytoplasmic domain of the beta 3 integrin subunit is not required for alpha v beta 3 postreceptor signaling events.
    Kieffer N; Melchior C; Guinet JM; Michels S; Gouon V; Bron N
    Cell Adhes Commun; 1996 Jul; 4(1):25-39. PubMed ID: 8870971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors.
    González-Manchón C; Butta N; Larrucea S; Arias-Salgado EG; Alonso S; López A; Parrilla R
    Thromb Haemost; 2004 Dec; 92(6):1377-86. PubMed ID: 15583747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.
    Chen P; Melchior C; Brons NH; Schlegel N; Caen J; Kieffer N
    J Biol Chem; 2001 Oct; 276(42):38628-35. PubMed ID: 11507099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation.
    Rosenberg N; Landau M; Luboshitz J; Rechavi G; Seligsohn U
    J Thromb Haemost; 2004 Jul; 2(7):1167-75. PubMed ID: 15219201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
    Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
    Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects.
    Kiyoi T; Tomiyama Y; Honda S; Tadokoro S; Arai M; Kashiwagi H; Kosugi S; Kato H; Kurata Y; Matsuzawa Y
    Blood; 2003 May; 101(9):3485-91. PubMed ID: 12506038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A point mutation in the integrin beta 3 cytoplasmic domain (S752-->P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa).
    Chen YP; O'Toole TE; Ylänne J; Rosa JP; Ginsberg MH
    Blood; 1994 Sep; 84(6):1857-65. PubMed ID: 8080992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Leu262Pro mutation in the integrin beta(3) subunit results in an alpha(IIb)-beta(3) complex that binds fibrin but not fibrinogen.
    Ward CM; Kestin AS; Newman PJ
    Blood; 2000 Jul; 96(1):161-9. PubMed ID: 10891446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative role of the membrane-proximal and -distal residues of the integrin beta3 cytoplasmic domain in regulation of talin-mediated alpha IIb beta3 activation.
    Hato T; Yamanouchi J; Tamura T; Yakushijin Y; Sakai I; Yasukawa M
    J Biol Chem; 2008 Feb; 283(9):5662-8. PubMed ID: 18174155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glanzmann thrombasthenia Frankfurt I is associated with a point mutation Thr176Ile in the N-terminal region of alpha IIb subunit integrin.
    Westrup D; Santoso S; Follert-Hagendorff K; Bassus S; Just M; Jablonka B; Kirchmaier CM
    Thromb Haemost; 2004 Nov; 92(5):1040-51. PubMed ID: 15543332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
    Grimaldi CM; Chen F; Wu C; Weiss HJ; Coller BS; French DL
    Blood; 1998 Mar; 91(5):1562-71. PubMed ID: 9473221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion-induced unclasping of cytoplasmic tails of integrin alpha(IIb)beta3.
    Podolnikova NP; O'Toole TE; Haas TA; Lam SC; Fox JE; Ugarova TP
    Biochemistry; 2009 Jan; 48(3):617-29. PubMed ID: 19117493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.